Effect of Platelet Inhibition According to Clopidogrel Dose in Patients With Chronic Kidney Disease
Status:
Completed
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
Impaired renal function is associated with reduced responsiveness to clopidogrel. There are
no studies which have shown a means by which to overcome platelet hyporesponsiveness in
patients with chronic kidney disease (CKD). The purpose of this study was to determine the
functional impact of cilostazol in patients with CKD undergoing hemodialysis.